AlphaMark Advisors’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $4K | Hold |
14,007
| – | – | ﹤0.01% | 541 |
|
|
2024
Q3 | $4K | Hold |
14,007
| – | – | ﹤0.01% | 598 |
|
|
2024
Q2 | $6K | Hold |
14,007
| – | – | ﹤0.01% | 603 |
|
|
2024
Q1 | $7K | Buy |
+14,007
| New | +$7K | ﹤0.01% | 586 |
|
|
2023
Q4 | – | Sell |
-14,007
| Closed | -$13K | – | 825 |
|
|
2023
Q3 | $13K | Hold |
14,007
| – | – | 0.01% | 484 |
|
|
2023
Q2 | $8K | Hold |
14,007
| – | – | ﹤0.01% | 448 |
|
|
2023
Q1 | $9K | Hold |
14,007
| – | – | ﹤0.01% | 430 |
|
|
2022
Q4 | $11K | Hold |
14,007
| – | – | 0.01% | 370 |
|
|
2022
Q3 | $10K | Hold |
14,007
| – | – | 0.01% | 419 |
|
|
2022
Q2 | $9K | Hold |
14,007
| – | – | ﹤0.01% | 413 |
|
|
2022
Q1 | $10K | Hold |
14,007
| – | – | ﹤0.01% | 408 |
|
|
2021
Q4 | $10K | Hold |
14,007
| – | – | ﹤0.01% | 403 |
|
|
2021
Q3 | $18K | Hold |
14,007
| – | – | 0.01% | 348 |
|
|
2021
Q2 | $21K | Buy |
+14,007
| New | +$21K | 0.01% | 331 |
|